Results 1 to 10 of about 71,664 (187)

¹⁷⁷Lu-trastuzumab radionuclide therapy: a promising strategy for trastuzumab-resistant brain metastases in HER2+ breast cancer. [PDF]

Mol Biomed
Santos L, Hrynchak I, Sereno J, Ferreira HRS, Silva M, Fonseca A, Almeida R, Teixeira P, Abrunhosa AJ, Gomes CMF.   +9 more
europepmc   +1 more source

Cost-effectiveness analysis of pembrolizumab plus trastuzumab and chemotherapy as first-line treatment for HER2-positive gastric or gastroesophageal junction adenocarcinoma. [PDF]

Front Med (Lausanne)
Yang H, Ge W, Jiang S, Lan X, Du X.
europepmc   +1 more source

Case Report: Dramatic response of trastuzumab rezetecan in an NSCLC patient with EGFR sensitive mutation and primary ERBB2 genetic alterations. [PDF]

Front Oncol
Zhang L, Zhang C, Wang H, Li Q, Wang Y, Huang X, Sun D, Hou H, Zhang L.   +8 more
europepmc   +1 more source

Serum NGAL and G-CSFR as Predictive and Prognostic Biomarkers for Trastuzumab-Based Therapy in HER2-Positive Gastric Cancer: A Retrospective Study. [PDF]

Cancer Manag Res
Ying J, Wang Z, Wang J, Xia M.
europepmc   +1 more source

Dramatic response to trastuzumab-deruxtecan in metastatic HER2-overexpressing vulvar extramammary Paget's disease: A case report. [PDF]

Gynecol Oncol Rep
Thomas M, Devouassoux-Shisheboran M, Lopez J, Descargues P, Gertych W, Caraivan I, You B, Péron J.   +7 more
europepmc   +1 more source

Development of a Homogeneous Trastuzumab-Triptolide Conjugate for Targeted Therapy of HER2-Overexpressing Ovarian Cancer. [PDF]

Bioconjug Chem
Fadayomi IE, Jangan M, Varghese D, Pires E, McCullagh J, Richardson A, Brunt AM, Li WW.   +7 more
europepmc   +1 more source

LC-MS/MS Quantification and Solvent-Exposure Modeling Reveal a Mismatch Between Linker Exposure and Payload Release in Wild-Type Trastuzumab-VC-PABC-MMAE in Rat Plasma. [PDF]

Biomed Chromatogr
Takahashi K, Yamazaki S, Matsuda Y.
europepmc   +1 more source

Response of HER2 positive gallbladder adenocarcinoma to trastuzumab emtansine (T-DM1): a case report and literature review. [PDF]

Front Oncol
Ling W, Zang J, Xiang F, Liu X, Chen S.
europepmc   +1 more source

Association of statin use and left ventricular function in patients with breast cancer receiving trastuzumab. [PDF]

Am Heart J Plus
Nochioka K, Terui Y, Udagawa A, Kato S, Toyoda S, Shimojima M, Izumiya Y, Yano T, Kitai T, Yasuda S, Sugimura K.   +10 more
europepmc   +1 more source

A Head-to-Head Comparison of Two Antibodies for HER2 Pretargeted PET Imaging via Bioorthogonal Click Chemistry. [PDF]

Pharmaceuticals (Basel)
Huang Y, Li C, Li T, Zhao J, Yang X, Zhang M, Liang Y.   +6 more
europepmc   +1 more source